BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro. Vet Ophthalmol 2020;23:160-70. [PMID: 31441218 DOI: 10.1111/vop.12704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Uberti B, Plaza A, Henríquez C. Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species. Front Vet Sci 2022;9:806069. [DOI: 10.3389/fvets.2022.806069] [Reference Citation Analysis]
2 Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis. Front Immunol 2020;11:609855. [PMID: 33488614 DOI: 10.3389/fimmu.2020.609855] [Reference Citation Analysis]
3 Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci 2020;7:278. [PMID: 32656249 DOI: 10.3389/fvets.2020.00278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cequier A, Sanz C, Rodellar C, Barrachina L. The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses. Animals (Basel) 2021;11:931. [PMID: 33805967 DOI: 10.3390/ani11040931] [Reference Citation Analysis]
5 Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro. Vet Ophthalmol 2020;23:160-70. [PMID: 31441218 DOI: 10.1111/vop.12704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
6 Weigand M, Hauck SM, Deeg CA, Degroote RL. Deviant proteome profile of equine granulocytes associates to latent activation status in organ specific autoimmune disease. J Proteomics 2021;230:103989. [PMID: 32977044 DOI: 10.1016/j.jprot.2020.103989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bellone RR. Genetics of Equine Ocular Disease. Vet Clin North Am Equine Pract 2020;36:303-22. [PMID: 32654784 DOI: 10.1016/j.cveq.2020.03.009] [Reference Citation Analysis]
8 Pleyer U, Neri P, Deuter C. New pharmacotherapy options for noninfectious posterior uveitis. Int Ophthalmol 2021;41:2265-81. [PMID: 33634341 DOI: 10.1007/s10792-021-01763-8] [Reference Citation Analysis]
9 Wiedemann C, Amann B, Degroote RL, Witte T, Deeg CA. Aberrant Migratory Behavior of Immune Cells in Recurrent Autoimmune Uveitis in Horses. Front Cell Dev Biol 2020;8:101. [PMID: 32211402 DOI: 10.3389/fcell.2020.00101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Sandmeyer LS, Kingsley NB, Walder C, Archer S, Leis ML, Bellone RR, Bauer BS. Risk factors for equine recurrent uveitis in a population of Appaloosa horses in western Canada. Vet Ophthalmol 2020;23:515-25. [PMID: 32086865 DOI: 10.1111/vop.12749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Himebaugh NE, Gilger BC. Role of Leptospira spp. testing and ocular examination in horses with equine recurrent uveitis: A retrospective study of 63 horses. Equine Vet Educ. [DOI: 10.1111/eve.13543] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]